Search Results for keywords:"National Institute of Allergy and Infectious Diseases"

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 9, 2025, from 12:00 p.m. to 5:00 p.m. This meeting will focus on reviewing and evaluating specific grant applications. It will be closed to the public to protect confidential information, such as trade secrets and personal information, associated with the grants. The meeting will take place at the NIH in Rockville, MD, and will be conducted as a video-assisted session.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting from April 14-16, 2025, to review and evaluate contract proposals related to the development of diagnostics for Mycoplasma genitalium infection. This meeting falls under specific federal regulations, which means it will not be open to the public to protect confidential and personal information. The discussions might involve trade secrets or sensitive commercial information. For more details, Dylan P. Flather, Ph.D., is the contact person available via email or phone.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 6-7, 2025. The meeting will review contract proposals related to vaccine adjuvant discovery and selection for fighting infectious and immune-mediated diseases. It will be conducted via video at their NIH office in Rockville, MD. The discussions are closed to the public to protect trade secrets and personal privacy.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 3-4, 2024, to review contract proposals related to vaccine adjuvant development. This meeting is closed to the public to protect sensitive information like trade secrets and personal privacy. The meeting will take place via video at the NIH facility in Rockville, MD. For further details, Michael M. Opata, Ph.D., is the contact person.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting on April 22, 2025, to discuss and evaluate contract proposals. This meeting will not be open to the public to protect confidential trade secrets, commercial information, and personal privacy. It will take place via video conference, and any inquiries can be directed to Anuja Mathew, Ph.D., at the National Institutes of Health.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 21, 2025. The meeting, which will happen via video, aims to review and evaluate contract proposals related to CRISPR-based in vitro diagnostics for detecting specific pathogens. This session is closed to the public to protect confidential information and privacy. The meeting details and contact information are provided for scientific inquiries.

The National Institute of Allergy and Infectious Diseases (NIAID) announced a closed meeting of their Special Emphasis Panel. The meeting, scheduled for April 30 to May 1, 2025, will review grant applications focused on strategies for eliminating HIV proteins. Because the discussions might involve confidential information or personal details, the meeting will not be open to the public. It will take place via video conference, and Stephen A. Gallo, Ph.D., will be the contact person for further inquiries.

The Office of Research Integrity (ORI) has found that Dr. Yibin Lin engaged in research misconduct while working as a postdoctoral fellow at the University of Texas Health Science Center. Dr. Lin knowingly falsified and plagiarized data in several published papers and submitted manuscripts, which led to their retraction. He even created fictitious author names to disguise his actions. As a consequence, Dr. Lin agreed to a voluntary ten-year exclusion from participating in any federal government contracts and serving in any advisory capacities to the Public Health Service.

The National Institute of Allergy and Infectious Diseases is holding two closed meetings to review and evaluate contract proposals. These meetings will focus on reagents for immunologic analysis of non-mammalian and underrepresented mammalian models as part of the Small Business Innovation Research (SBIR) program. The first meeting for Phase I will occur on January 28, 2021, from 10:00 a.m. to 6:00 p.m., and the second meeting for Phase II will take place on January 29, 2021, from 10:00 a.m. to 2:00 p.m. Both meetings will be held virtually and closed to the public to protect confidential trade secrets and personal privacy.

The National Institute of Allergy and Infectious Diseases (NIAID) announced a closed meeting to discuss and evaluate contract proposals as part of a collaborative effort with the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). This meeting is set to take place virtually on February 2, 2021, from 11:00 a.m. to 4:00 p.m. The discussions will include confidential trade secrets or commercial information and personal details, so it will be closed to the public. Dr. Lynn Rust is the contact person for more information about this meeting.